Literature DB >> 3166397

Carcinoma of the gallbladder. A clinicopathology of 103 patients and a newly proposed staging.

K Yamaguchi1, M Enjoji.   

Abstract

Tissue samples from 103 patients with gallbladder carcinoma were examined, using 5-mm stepwise tissue sections. Three pathologic stages were used: Stage I; carcinoma invading not further than the muscle coat of the gallbladder, with or without extension along Rokitansky-Aschoff sinuses in the subserosa (11 cases); Stage II, carcinoma extending to the subserosal fibroadipose tissue of the gallbladder (73 cases); and Stage III: carcinoma invading the adjacent organs such as the duodenum, liver, and colon (19 cases). In the 11 patients with Stage I carcinoma, there was no apparent lymph node metastasis and all remained well for 3 months to 14 years after the initial operation. The cumulative 3-year survival rate of Stage I (100%) was significantly higher than of Stage II (40%) and Stage III (10%) (P less than 0.01, P less than 0.001). The Stage I tumors, therefore, can be defined as early carcinoma of the gallbladder. Dysplastic epithelium was seen in the mucosa adjacent to the malignant lesion in 57% of those with gallbladder carcinoma: 73% in Stage I, 59% in Stage II, and 42% in Stage III. Nine gallbladders had multiple foci of adenocarcinoma in a background of a diffuse dysplasia. Immunohistochemical study for carcinoembryonic antigen and carbohydrate antigen 19-9 resulted in positive staining of the dysplastic epithelial element adjacent to the invasive carcinoma and, in a similar fashion, in the carcinoma itself, thereby indicating a close relation between the epithelial dysplasia and adenocarcinoma of the gallbladder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166397     DOI: 10.1002/1097-0142(19881001)62:7<1425::aid-cncr2820620730>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Simultaneous presence of xanthogranulomatous cholecystitis and gallbladder cancer.

Authors:  A-Hon Kwon; Noriko Sakaida
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

2.  Epithelial dysplasia in Caroli's disease.

Authors:  N I Walker; R W Strong
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  NATURAL HISTORY OF CARCINOMA OF THE GALLBLADDER AND ITS INFLUENCES ON MANAGEMENT.

Authors:  S K Kochar; P Subhas
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy.

Authors:  Y Shirai; K Yoshida; K Tsukada; T Muto
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  Primary gallbladder carcinoma: imaging findings in 50 patients with pathologic correlation.

Authors:  T Franquet; M Montes; Y Ruiz de Azua; F J Jimenez; R Cozcolluela
Journal:  Gastrointest Radiol       Date:  1991

6.  Xanthogranulomatous Cholecystitis: Analysis of 108 Patients.

Authors:  Osman Yucel; Mehmet Ali Uzun; Metin Tilki; Sevcan Alkan; Zeynep Gamze Kilicoglu; Ceren Canbey Goret
Journal:  Indian J Surg       Date:  2016-06-01       Impact factor: 0.656

7.  Hepatic metastasis after laparoscopic cholecystectomy for polypoid gallbladder cancer followed by radical surgery.

Authors:  T Nishizaki; T Matsumata; M Hashizume; T Maeda; K Otsuka; K Sugimachi
Journal:  Surg Endosc       Date:  1994-12       Impact factor: 4.584

8.  Role of laparoscopic cholecystectomy in treating gallbladder polyps.

Authors:  K Kubota; Y Bandai; Y Otomo; A Ito; M Watanabe; H Toyoda; Y Idezuki
Journal:  Surg Endosc       Date:  1994-01       Impact factor: 4.584

9.  A patient with early gallbladder cancer derived from a Rokitanski-Aschoff sinus.

Authors:  T Funabiki; S Matsumoto; N Tsukada; T Kimura; S Yoshizaki; Y Horibe
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Pathology of carcinoma of the gallbladder.

Authors:  K Sumiyoshi; E Nagai; K Chijiiwa; F Nakayama
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.